Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, are pleased to announce a new manufacturing and supply partnership that will see HDB products reintroduced to healthcare professionals and patients across the United Kingdom (UK).
The agreement combines Herdade das Barrocas‘ cultivation capabilities in Portugal with Curaleaf Laboratories’ MHRA-approved manufacturing, quality assurance and distribution infrastructure in the UK. Together, the companies will deliver a range of cannabis-based medicinal products to UK prescribers and patients, strengthening supply chain resilience and expanding treatment options within the rapidly growing UK medical cannabis sector.
The partnership marks the return of Herdade das Barrocas products to the UK market, providing patients and healthcare professionals with renewed access to both cultivars that have previously been recognised market, as well as new strains cultivated and manufactured based on clinical need.
Under the agreement, cannabis flower cultivated by Herdade das Barrocas will be supplied to Curaleaf Laboratories for UK manufacturing, packaging and distribution, ensuring all products meet the quality and regulatory standards required for UK patient access.